Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amanda K Debes, PhD"'
Autor:
Hamada S Badr, PhD, Josh M Colston, PhD, Nhat-Lan H Nguyen, BA, Yen Ting Chen, MD, Eleanor Burnett, MPH, Syed Asad Ali, MPH, Ajit Rayamajhi, MD, Syed M Satter, MPH, Nguyen Van Trang, PhD, Daniel Eibach, PD, Ralf Krumkamp, DrPH, Jürgen May, MD, Ayola Akim Adegnika, PhD, Gédéon Prince Manouana, PhD, Peter Gottfried Kremsner, MD, Roma Chilengi, MSc, Luiza Hatyoka, PhD, Amanda K Debes, PhD, Jerome Ateudjieu, PhD, Abu S G Faruque, MPH, M Jahangir Hossain, MSc, Suman Kanungo, PhD, Karen L Kotloff, MD, Inácio Mandomando, PhD, M Imran Nisar, PhD, Richard Omore, PhD, Samba O Sow, MSc, Anita K M Zaidi, SM, Nathalie Lambrecht, PhD, Bright Adu, PhD, Nicola Page, MPH, James A Platts-Mills, MD, Cesar Mavacala Freitas, MD, Tuula Pelkonen, PhD, Per Ashorn, PhD, Kenneth Maleta, PhD, Tahmeed Ahmed, PhD, Pascal Bessong, PhD, Zulfiqar A Bhutta, PhD, Carl Mason, MD, Estomih Mduma, PhD, Maribel P Olortegui, MPH, Pablo Peñataro Yori, MPH, Aldo A M Lima, PhD, Gagandeep Kang, PhD, Jean Humphrey, ScD, Robert Ntozini, MPH, Andrew J Prendergast, DPhil, Kazuhisa Okada, PhD, Warawan Wongboot, PhD, Nina Langeland, PhD, Sabrina J Moyo, PhD, James Gaensbauer, MD, Mario Melgar, MD, Matthew Freeman, PhD, Anna N Chard, MPH, Vonethalom Thongpaseuth, MD, Eric Houpt, MD, Benjamin F Zaitchik, PhD, Margaret N Kosek, MD
Publikováno v:
The Lancet Global Health, Vol 11, Iss 3, Pp e373-e384 (2023)
Summary: Background: Diarrhoeal disease is a leading cause of childhood illness and death globally, and Shigella is a major aetiological contributor for which a vaccine might soon be available. The primary objective of this study was to model the spa
Externí odkaz:
https://doaj.org/article/bf7cee71ef0a40cfb55dc0350ac997ee
Autor:
Dr. Andrew S Azman, PhD, Lucy A Parker, PhD, John Rumunu, MPH, Fisseha Tadesse, MPH, Francesco Grandesso, MPH, Lul L Deng, MD, Richard Laku Lino, MPH, Bior K Bior, PhD, Michael Lasuba, MS, Anne-Laure Page, PhD, Lameck Ontweka, BS, Augusto E Llosa, PhD, Sandra Cohuet, MD, Lorenzo Pezzoli, PhD, Dossou Vincent Sodjinou, MD, Abdinasir Abubakar, MD, Amanda K Debes, PhD, Allan M Mpairwe, MPH, Joseph F Wamala, MPH, Christine Jamet, MPH, Justin Lessler, PhD, Prof. David A Sack, MD, Marie-Laure Quilici, PhD, Iza Ciglenecki, MD, Francisco J Luquero, PhD
Publikováno v:
The Lancet Global Health, Vol 4, Iss 11, Pp e856-e863 (2016)
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2–4 weeks between doses. Evidence from previous studies suggests that a single dose of oral cholera vaccine might provide s
Externí odkaz:
https://doaj.org/article/62b3adcc0ed74958b342df4b2abae42d